Repligen | RGEN - بدهی های جاری





بدهی های جاری تغییر دادن تاریخ
Agilent USD 2.23B 113M 2025-12
Align Technology USD 1.92B 46.45M 2025-12
Bio Techne USD 140.43M 4.12M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Bruker USD 1.28B 11.1M 2025-12
Charles River Laboratories USD 1.12B 1.57M 2025-12
Danaher USD 6.81B 483M 2025-12
Dentsply International USD 1.34B 62M 2025-12
General Electric Aerospace USD 38.98B 1.78B 2025-12
Henry Schein USD 3.23B 79M 2025-12
Illumina USD 1.59B 377M 2025-12
IQVIA Holdings USD 8.34B 170M 2025-12
Mettler Toledo International USD 1.2B 5.99M 2025-12
Myriad Genetics USD 133.8M 14.2M 2025-12
OraSure Technologies USD 39.8M 453K 2025-12
Pacific Biosciences Of California USD 72.83M 9.62M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Repligen USD 135.83M 4.69M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Standard Biotools USD 108.31M 343K 2025-12
Thermo Fisher Scientific USD 15.19B 301M 2025-12
Waters USD 1.24B 11.8M 2025-12
West Pharmaceutical Services USD 654.9M 19.5M 2025-12